ClinicalTrials.gg
CompletedNCT07052188Updated May 13, 2026

Effect of Preop Stent Duration on SFR and Secondary Intervention in RIRS

An interventional study of without any preoperative stenting and (DJ) stent placed with sedation and undergo RIRS within 2-4 weeks in Stone, Urinary and Stone, Kidney, sponsored by Bedreddin Kalyenci. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-13.

Primary conditionKidney CalculiRegistry: Urinary CalculiReclassifiedWhy we changed it
Registry
Urinary Calculi — the first condition term the registry derived for this study.
ClinicalTrials.gg
Kidney Calculi
Why
  1. The study's listed conditions name Kidney Calculi, a narrower term within Urinary Calculi.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Bedreddin Kalyenci · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate how placing a stent before surgery (preoperative stenting or passive dilation) affects the success rate of retrograde intrarenal surgery (RIRS), which is performed for kidney stones. Specifically, we will examine whether stenting improves the chance of becoming stone-free after surgery and reduces the need for a second surgical procedure.

02

Conditions studied

  • Stone, Urinary
  • Stone, Kidney

Browse trials for

Keywords

  • Ureteral stent
  • retrograde intrarenal surgery
  • prestenting
  • preoperative ureteral stenting
03

In context

Kidney Calculi Reclassified

509 studies on the registry are indexed under Kidney Calculi; 146 are open to participants now.

This study's enrollment of 210 is above the median of 86 across 391 interventional studies indexed under Kidney Calculi.

Browse Kidney Calculi studies →

Lead sponsor

This is the only study on the registry with Bedreddin Kalyenci as lead sponsor.

Compared within Kidney Calculi, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Urinary Calculi. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over 18 years of age with an indication for RIRS (Retrograde Intrarenal Surgery)

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 or over 65 years of age
  • Patients who cannot be followed up in the postoperative period
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
210 participants (actual)

Study arms

  • Experimental
    Patients will have RIRS without any preoperative double J (DJ) stenting

    Procedure: without any preoperative stenting

  • Experimental
    Patients will have a double-J (DJ) stent placed with sedation and undergo RIRS within 2-4 weeks.

    Procedure: (DJ) stent placed with sedation and undergo RIRS within 2-4 weeks

  • Experimental
    Patients will have a DJ stent placed with sedation and undergo RIRS within 4-6 weeks.

    Procedure: Patients will have a DJ stent placed with sedation and undergo RIRS within 4-6 weeks.

Interventions

  • Procedurewithout any preoperative stenting

    Patients will have RIRS without any preoperative stenting.

  • Procedure(DJ) stent placed with sedation and undergo RIRS within 2-4 weeks

    Patients will have a double-J (DJ) stent placed with sedation and undergo RIRS within 2-4 weeks.

  • ProcedurePatients will have a DJ stent placed with sedation and undergo RIRS within 4-6 weeks.

    Patients will have a DJ stent placed with sedation and undergo RIRS within 4-6 weeks

06

What researchers measure

Primary outcomes

  1. Number of Participants with stone-free

    Time frame: in the first month after surgery

  2. Number of Participants with additional surgery was needed

    Time frame: in the first month after surgery

Secondary outcomes

  1. Number of Participants with postoperative complications

    Time frame: within 1 month after surgery

07

Study locations

1 site
  • Adıyaman University
    Adıyaman, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: One year after the completion of the study

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07052188
Lead sponsor
Bedreddin Kalyenci
Responsible party
Bedreddin Kalyenci (Principal Investigator, Adiyaman University) — Sponsor-investigator
First posted
Jul 4, 2025
Start date
Jun 26, 2025
Primary completion
Feb 15, 2026
Completion
Mar 28, 2026
Last update
May 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion